• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BioXcel Therapeutics, Inc. - Common Stock (NQ:BTAI)

0.7188 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,153,309
Open 0.7188
Bid (Size) 0.2798 (2,900)
Ask (Size) 0.2800 (5,000)
Prev. Close 0.7188
Today's Range 0.7188 - 0.7188
52wk Range 0.7001 - 5.190
Shares Outstanding 19,996,000
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
August 17, 2026
Via Chartmill
There are notable gap-ups and gap-downs in today's session. ↗
August 17, 2026
Via Chartmill

Performance

YTD
-57.7%
-57.7%
1 Month
-14.9%
-14.9%
3 Month
-43.0%
-43.0%
6 Month
-59.2%
-59.2%
1 Year
-81.8%
-81.8%

More News

Read More
Let's take a look at the stocks that are in motion in today's session. ↗
July 14, 2026
Via Chartmill
News headline image
Levi & Korsinsky, LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of BioXcel Therapeutics, Inc.
March 23, 2026
From Levi & Korsinsky, LLP
Via GlobeNewswire
BioXcel Stock Shoots Up 3% Pre-Market After Company Announces Positive Efficacy Data For Agitation Drug In Study ↗
September 10, 2025
Via Stocktwits
BioXcel’s Sublingual Film Well-Tolerated In Bipolar, Schizophrenia Trial In At-Home Settings, Retail Says Buy Now Or Regret Later ↗
August 27, 2025
Via Stocktwits
BioXcel Sparks Retail Frenzy As Stock Soars Ahead Of Phase 3 Results For Bipolar, Schizophrenia Drug ↗
August 27, 2025
Via Stocktwits
The trading volume of these stocks is deviating from the norm in today's session. ↗
March 06, 2026
Via Chartmill
News headline image
Why Did BTAI Stock Surge 20% In Pre-Market Today? ↗
March 05, 2026
Via Stocktwits
News headline image
Halper Sadeh LLC Encourages BioXcel Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights
January 15, 2026
From Halper Sadeh LLC
Via Business Wire
News headline image
Halper Sadeh LLC Encourages BioXcel Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights
October 24, 2025
From Halper Sadeh LLC
Via Business Wire
News headline image
BioXcel Drug Calms Agitation At Home For Schizophrenia, Bipolar Patients ↗
September 10, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
September 08, 2025
Via Benzinga
News headline image
EXCLUSIVE: August's 20 Most-Searched Tickers On Benzinga Pro – Where Do Opendoor, Palantir, BitMine Immersion, Apple Stock Rank? ↗
September 02, 2025
Via Benzinga
News headline image
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
August 27, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
August 27, 2025
Via Benzinga
News headline image
Which stocks are experiencing notable movement on Wednesday? ↗
August 27, 2025
Via Chartmill
News headline image
BioXcel Seeks FDA Label Expansion For Schizophrenia Treatment ↗
August 27, 2025
Via Benzinga
News headline image
The market is filled with gapping stocks in Wednesday's session. ↗
August 27, 2025
Via Chartmill
News headline image
Why MongoDB Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket ↗
August 27, 2025
Via Benzinga
News headline image
BioXcel Stock Surges 19% In After-Hours Trading: What You Need To Know ↗
August 27, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
August 26, 2025
Via Benzinga
News headline image
Get insights into the top gainers and losers of Tuesday's after-hours session. ↗
August 26, 2025
Via Chartmill
News headline image
Tuesday's pre-market session: top gainers and losers ↗
August 19, 2025
Via Chartmill
News headline image
Synergy Corp. (NASDAQ: SNYR) 1,600+ Nationwide Store Rollout – PPCB, SNGX, BTAI, HIT + Other Disruptive Stocks Moving Now!
August 18, 2025
Via AB Newswire
Topics Artificial Intelligence

Frequently Asked Questions

Is BioXcel Therapeutics, Inc. - Common Stock publicly traded?
Yes, BioXcel Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does BioXcel Therapeutics, Inc. - Common Stock trade on?
BioXcel Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for BioXcel Therapeutics, Inc. - Common Stock?
The ticker symbol for BioXcel Therapeutics, Inc. - Common Stock is BTAI on the Nasdaq Stock Market
What is the current price of BioXcel Therapeutics, Inc. - Common Stock?
The current price of BioXcel Therapeutics, Inc. - Common Stock is 0.7188
When was BioXcel Therapeutics, Inc. - Common Stock last traded?
The last trade of BioXcel Therapeutics, Inc. - Common Stock was at 08/27/26 04:00 PM ET
What is the market capitalization of BioXcel Therapeutics, Inc. - Common Stock?
The market capitalization of BioXcel Therapeutics, Inc. - Common Stock is 14.37M
How many shares of BioXcel Therapeutics, Inc. - Common Stock are outstanding?
BioXcel Therapeutics, Inc. - Common Stock has 14M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap